GIPOTIREOZ


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Full Text

Restricted Access

About the authors

- -

References

  1. Клинические рекомендации. Гипотиреоз. Российская ассоциация эндокринологов. 2021. Рубрикатор клинических рекомендаций Минздрава России. ID: 531. Доступ: https://cr.minzdrav.gov.ru/schema/531_3 (дата обращения - 01.11.2022)
  2. Perez C.L., Araki F.S., Graf H., de Carvalho G.A. Serum thyrotropin levels following levothyroxine administration at breakfast. Thyroid. 2013; 23(7): 779-84. https://dx.doi.org/10.1089/thy.2012.0435.
  3. Ross D.S. Serum thyroid-stimulating hormone measurement for assessment of thyroid function and disease. Endocrinol Metab Clin North Am. 2001; 30(2): 245-64, vii. https://dx.doi.org/10.1016/s0889-8529(05)70186-9.
  4. Woeber K.A. Levothyroxine therapy and serum free thyroxine and free triiodothyronine concentrations. J Endocrinol Invest. 2002; 25(2): 106-9. https://dx.doi.org/10.1007/BF03343972.
  5. Campbell N.R., Hasinoff B.B., Stalts H. et al. Ferrous sulfate reduces thyroxine efficacy in patients with hypothyroidism. Ann Intern Med. 1992; 117(12): 1010-13. https://dx.doi.org/10.7326/0003-4819-117-12-1010.
  6. Zamfirescu I., Carlson H.E. Absorption of levothyroxine when coadministered with various calcium formulations. Thyroid. 2011; 21(5): 483-86. https://dx.doi.org/10.1089/thy.2010.0296.
  7. Roos A., Linn-Rasker S.P., van Domburg R.T. et al. The starting dose of levothyroxine in primary hypothyroidism treatment: A prospective, randomized, double-blind trial. Arch Intern Med. 2005; 165(15): 1714-20. https://dx.doi.org/10.1001/archinte.165.15.1714.
  8. He Q., Heo M., Heshka S. et al. Total body potassium differs by sex and race across the adult age span. Am J Clin Nutr. 2003; 78(1): 72-77. https://dx.doi.org/10.1093/ajcn/78.1.72.
  9. Eisenberg M., Distefano J.J. TSH-based protocol, tablet instability, and absorption effects on L-T4 bioequivalence. Thyroid. 2009; 19(2): 103-10. https://dx.doi.org/10.1089/thy.2008.0148.
  10. Biondi B., Palmieri E.A., Lombardi G., Fazio S. Effects of subclinical thyroid dysfunction on the heart. Ann Intern Med. 2002; 137(11): 904-14. https://dx.doi.org/10.7326/0003-4819-137-11-200212030-00011.
  11. Paul T.L., Kerrigan J., Kelly A.M. et al. Long-term thyroxine therapy is associated with decreased hip bone density in premenopausal women. JAMA. 1988; 259(21): 3137-41.

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies